The dominant truncating mutations in GLI3 that cause PHS result in constitutive availability of the GLI3-R form, and a consequent imbalance relative to its activator form (Démurger et al. 2015, Fig. 1). The gene discussed is GLI3; the disease is Pallister-Hall syndrome.